Nudt17, a member of the Nudix hydrolase family, has been shown to possess mRNA decapping activity in vitro, contributing to gene expression regulation and mRNA decay [2]. It may also be involved in pathways related to inositol pyrophosphate catabolism, which impacts plant growth and development [5]. Understanding Nudt17's function through genetic models could provide insights into its biological importance.

In humans, Nudt17 gene polymorphisms have been associated with various disease risks. In a Chinese Han population, specific single nucleotide polymorphisms (SNPs) in Nudt17 were associated with a decreased breast cancer risk, with the rs9286836 G allele and rs2004659 G allele carriers having reduced risks [1]. Additionally, rs9286836 (Nudt17) on chromosome 1 showed a significant association with male gout in a genome-wide association study [3]. In clozapine-related neutropaenia, Nudt17 was identified as a gene whose expression may be causally related to the lowest absolute neutrophil count during clozapine treatment [4]. In clear cell renal cell carcinoma, low Nudt17 expression was associated with poorer overall survival rates, indicating its potential prognostic value [6].

In summary, Nudt17 plays a role in mRNA decapping and is associated with various human diseases such as breast cancer, gout, clozapine-related neutropaenia, and clear cell renal cell carcinoma. The study of Nudt17 through genetic models, like the analysis of its polymorphisms, provides valuable insights into its functions and disease associations, which could potentially contribute to disease prevention and treatment strategies.